[{"start_date": "2025-07-01", "end_date": "2025-09-30", "filing_date": "2025-10-23", "acceptance_datetime": "2025-10-22T21:35:43Z", "timeframe": "quarterly", "fiscal_period": "Q3", "fiscal_year": "2025", "cik": "0001607678", "sic": "2834", "tickers": ["VKTX"], "company_name": "Viking Therapeutics, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001193125-25-247059", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001193125-25-247059/files/vktx-20250930_htm.xml", "financials": {"balance_sheet": {"equity": {"value": 713030000.0, "unit": "USD", "label": "Equity", "order": 1400}, "liabilities": {"value": 26385000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "liabilities_and_equity": {"value": 739415000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "assets": {"value": 739415000.0, "unit": "USD", "label": "Assets", "order": 100}, "other_current_liabilities": {"value": 21654000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "accounts_payable": {"value": 4413000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "current_assets": {"value": 738703000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "noncurrent_liabilities": {"value": 318000, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "noncurrent_assets": {"value": 712000, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "equity_attributable_to_parent": {"value": 713030000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "current_liabilities": {"value": 26067000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}}, "income_statement": {"diluted_earnings_per_share": {"value": -0.81, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "net_income_loss_available_to_common_stockholders_basic": {"value": -90787000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "net_income_loss": {"value": -90787000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "basic_average_shares": {"value": 112320000.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "research_and_development": {"value": 89953000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "net_income_loss_attributable_to_parent": {"value": -90787000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "operating_income_loss": {"value": -98561000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "income_loss_from_continuing_operations_before_tax": {"value": -90787000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "income_loss_from_continuing_operations_after_tax": {"value": -90787000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "operating_expenses": {"value": 98561000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "other_operating_expenses": {"value": 8608000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "diluted_average_shares": {"value": 112320000.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "basic_earnings_per_share": {"value": -0.81, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss": {"value": -90247000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_parent": {"value": -90247000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "other_comprehensive_income_loss": {"value": -90247000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}}, "cash_flow_statement": {"net_cash_flow_from_financing_activities_continuing": {"value": 480000, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_financing_activities": {"value": 480000, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow": {"value": 66502000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_investing_activities_continuing": {"value": 160025000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_operating_activities": {"value": -94003000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_investing_activities": {"value": 160025000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_continuing": {"value": 66502000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_operating_activities_continuing": {"value": -94003000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}}}}, {"start_date": "2025-04-01", "end_date": "2025-06-30", "filing_date": "2025-07-23", "acceptance_datetime": "2025-07-23T21:01:26Z", "timeframe": "quarterly", "fiscal_period": "Q2", "fiscal_year": "2025", "cik": "0001607678", "sic": "2834", "tickers": ["VKTX"], "company_name": "Viking Therapeutics, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-25-097950", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-25-097950/files/vktx-20250630_htm.xml", "financials": {"comprehensive_income": {"comprehensive_income_loss": {"value": -65511000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_parent": {"value": -65511000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "other_comprehensive_income_loss": {"value": -65511000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}}, "balance_sheet": {"noncurrent_assets": {"value": 834000, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "noncurrent_liabilities": {"value": 410000, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "assets": {"value": 827851000.0, "unit": "USD", "label": "Assets", "order": 100}, "current_liabilities": {"value": 31980000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "accounts_payable": {"value": 5494000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "equity_attributable_to_parent": {"value": 795461000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "equity": {"value": 795461000.0, "unit": "USD", "label": "Equity", "order": 1400}, "liabilities": {"value": 32390000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "current_assets": {"value": 827017000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "other_current_liabilities": {"value": 26486000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "liabilities_and_equity": {"value": 827851000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}}, "cash_flow_statement": {"net_cash_flow_continuing": {"value": -4048000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_operating_activities": {"value": -47061000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow": {"value": -4048000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_investing_activities_continuing": {"value": 42506000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_financing_activities_continuing": {"value": 507000, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_operating_activities_continuing": {"value": -47061000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_financing_activities": {"value": 507000, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_investing_activities": {"value": 42506000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}}, "income_statement": {"net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "other_operating_expenses": {"value": 14421000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "basic_average_shares": {"value": 112134000.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "net_income_loss_attributable_to_parent": {"value": -65561000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "net_income_loss_available_to_common_stockholders_basic": {"value": -65561000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "income_loss_from_continuing_operations_after_tax": {"value": -65561000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "basic_earnings_per_share": {"value": -0.58, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "net_income_loss": {"value": -65561000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "operating_expenses": {"value": 74574000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "diluted_average_shares": {"value": 112134000.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "research_and_development": {"value": 60153000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "operating_income_loss": {"value": -74574000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "income_loss_from_continuing_operations_before_tax": {"value": -65561000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "diluted_earnings_per_share": {"value": -0.58, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}}}}, {"start_date": "2025-01-01", "end_date": "2025-03-31", "filing_date": "2025-04-24", "acceptance_datetime": "2025-04-24T20:37:31Z", "timeframe": "quarterly", "fiscal_period": "Q1", "fiscal_year": "2025", "cik": "0001607678", "sic": "2834", "tickers": ["VKTX"], "company_name": "Viking Therapeutics, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-25-058129", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-25-058129/files/vktx-20250331_htm.xml", "financials": {"comprehensive_income": {"other_comprehensive_income_loss": {"value": 572000, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss_attributable_to_parent": {"value": -45057000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss": {"value": -45057000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}}, "income_statement": {"operating_expenses": {"value": 55469000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "net_income_loss_attributable_to_parent": {"value": -45629000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "income_loss_from_continuing_operations_after_tax": {"value": -45629000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "net_income_loss_available_to_common_stockholders_basic": {"value": -45629000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "basic_average_shares": {"value": 112069000.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "diluted_average_shares": {"value": 112069000.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "other_operating_expenses": {"value": 14078000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "income_loss_from_continuing_operations_before_tax": {"value": -45629000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "basic_earnings_per_share": {"value": -0.41, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "operating_income_loss": {"value": -55469000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "diluted_earnings_per_share": {"value": -0.41, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "research_and_development": {"value": 41391000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "net_income_loss": {"value": -45629000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}}, "balance_sheet": {"noncurrent_liabilities": {"value": 502000, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "accounts_payable": {"value": 7702000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "equity_attributable_to_parent": {"value": 846918000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "other_current_liabilities": {"value": 11871000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "noncurrent_assets": {"value": 970000, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "current_assets": {"value": 866023000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "current_liabilities": {"value": 19573000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "assets": {"value": 866993000.0, "unit": "USD", "label": "Assets", "order": 100}, "liabilities_and_equity": {"value": 866993000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "equity": {"value": 846918000.0, "unit": "USD", "label": "Equity", "order": 1400}, "liabilities": {"value": 20075000.0, "unit": "USD", "label": "Liabilities", "order": 600}}, "cash_flow_statement": {"net_cash_flow_from_investing_activities_continuing": {"value": 63245000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_financing_activities": {"value": 349000, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_investing_activities": {"value": 63245000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow": {"value": 11263000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_operating_activities": {"value": -52331000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_financing_activities_continuing": {"value": 349000, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_continuing": {"value": 11263000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_operating_activities_continuing": {"value": -52331000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}}}}, {"start_date": "2024-10-01", "end_date": "2024-12-31", "timeframe": "quarterly", "fiscal_period": "Q4", "fiscal_year": "2024", "cik": "0001607678", "sic": "2834", "tickers": ["VKTX"], "company_name": "Viking Therapeutics, Inc.", "financials": {"comprehensive_income": {"comprehensive_income_loss_attributable_to_parent": {"value": -37837000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "other_comprehensive_income_loss": {"value": -2420000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss": {"value": -37837000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}}, "income_statement": {"basic_earnings_per_share": {"value": -0.32000000000000006, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "other_operating_expenses": {"value": 15251000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "diluted_earnings_per_share": {"value": -0.32000000000000006, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "basic_average_shares": {"value": 775000, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "income_loss_from_continuing_operations_after_tax": {"value": -35417000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "diluted_average_shares": {"value": 775000, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "operating_income_loss": {"value": -46238000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "income_loss_from_continuing_operations_before_tax": {"value": -35416000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "net_income_loss_available_to_common_stockholders_basic": {"value": -35417000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "net_income_loss_attributable_to_parent": {"value": -35417000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "net_income_loss": {"value": -35417000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "research_and_development": {"value": 30987000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "operating_expenses": {"value": 46238000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}}, "cash_flow_statement": {"net_cash_flow_from_operating_activities": {"value": -31181000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_investing_activities_continuing": {"value": 6584000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_financing_activities": {"value": 1000000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_investing_activities": {"value": 6584000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow": {"value": -23597000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_operating_activities_continuing": {"value": -31181000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_financing_activities_continuing": {"value": 1000000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_continuing": {"value": -23597000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}}, "balance_sheet": {"noncurrent_assets": {"value": 1105000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "equity": {"value": 880278000.0, "unit": "USD", "label": "Equity", "order": 1400}, "current_liabilities": {"value": 27413000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "other_current_liabilities": {"value": 17600000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "accounts_payable": {"value": 9813000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "assets": {"value": 908321000.0, "unit": "USD", "label": "Assets", "order": 100}, "current_assets": {"value": 907216000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "liabilities_and_equity": {"value": 908321000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "equity_attributable_to_parent": {"value": 880278000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "liabilities": {"value": 28043000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "noncurrent_liabilities": {"value": 630000, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}}}}, {"start_date": "2024-07-01", "end_date": "2024-09-30", "filing_date": "2024-10-23", "acceptance_datetime": "2024-10-23T21:00:19Z", "timeframe": "quarterly", "fiscal_period": "Q3", "fiscal_year": "2024", "cik": "0001607678", "sic": "2834", "tickers": ["VKTX"], "company_name": "Viking Therapeutics, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-24-116708", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-24-116708/files/vktx-20240930_htm.xml", "financials": {"comprehensive_income": {"comprehensive_income_loss_attributable_to_parent": {"value": -21036000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "other_comprehensive_income_loss": {"value": -21036000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss": {"value": -21036000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}}, "income_statement": {"net_income_loss": {"value": -24940000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "net_income_loss_available_to_common_stockholders_basic": {"value": -24940000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "income_loss_from_continuing_operations_before_tax": {"value": -24940000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "basic_average_shares": {"value": 110911000.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "research_and_development": {"value": 22785000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "diluted_average_shares": {"value": 110911000.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "diluted_earnings_per_share": {"value": -0.22, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "basic_earnings_per_share": {"value": -0.22, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "income_loss_from_continuing_operations_after_tax": {"value": -24940000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "operating_income_loss": {"value": -36556000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "net_income_loss_attributable_to_parent": {"value": -24940000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "operating_expenses": {"value": 36556000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "other_operating_expenses": {"value": 13771000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}}, "balance_sheet": {"noncurrent_liabilities": {"value": 755000, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "equity_attributable_to_parent": {"value": 911448000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "noncurrent_assets": {"value": 1239000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "equity": {"value": 911448000.0, "unit": "USD", "label": "Equity", "order": 1400}, "current_liabilities": {"value": 25685000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "current_assets": {"value": 936649000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "accounts_payable": {"value": 254000, "unit": "USD", "label": "Accounts Payable", "order": 710}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "assets": {"value": 937888000.0, "unit": "USD", "label": "Assets", "order": 100}, "other_current_liabilities": {"value": 25431000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "liabilities_and_equity": {"value": 937888000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "liabilities": {"value": 26440000.0, "unit": "USD", "label": "Liabilities", "order": 600}}, "cash_flow_statement": {"net_cash_flow_from_operating_activities": {"value": -21962000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_continuing": {"value": 6461000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_investing_activities_continuing": {"value": 25901000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_financing_activities": {"value": 2522000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow": {"value": 6461000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_operating_activities_continuing": {"value": -21962000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_financing_activities_continuing": {"value": 2522000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_investing_activities": {"value": 25901000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}}}}, {"start_date": "2024-04-01", "end_date": "2024-06-30", "filing_date": "2024-07-24", "acceptance_datetime": "2024-07-24T21:00:23Z", "timeframe": "quarterly", "fiscal_period": "Q2", "fiscal_year": "2024", "cik": "0001607678", "sic": "2834", "tickers": ["VKTX"], "company_name": "Viking Therapeutics, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-24-086111", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-24-086111/files/vktx-20240630_htm.xml", "financials": {"balance_sheet": {"current_assets": {"value": 945724000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "liabilities_and_equity": {"value": 946839000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "liabilities": {"value": 25859000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "other_current_liabilities": {"value": 14003000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "accounts_payable": {"value": 11090000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "equity_attributable_to_parent": {"value": 920980000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "noncurrent_liabilities": {"value": 766000, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "noncurrent_assets": {"value": 1115000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "current_liabilities": {"value": 25093000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "assets": {"value": 946839000.0, "unit": "USD", "label": "Assets", "order": 100}, "equity": {"value": 920980000.0, "unit": "USD", "label": "Equity", "order": 1400}}, "income_statement": {"basic_earnings_per_share": {"value": -0.2, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "net_income_loss": {"value": -22250000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "research_and_development": {"value": 23769000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "net_income_loss_available_to_common_stockholders_basic": {"value": -22250000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "basic_average_shares": {"value": 110390000.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "diluted_average_shares": {"value": 110390000.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "other_operating_expenses": {"value": 10285000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "operating_expenses": {"value": 34054000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "net_income_loss_attributable_to_parent": {"value": -22250000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "operating_income_loss": {"value": -34054000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "income_loss_from_continuing_operations_before_tax": {"value": -22250000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "diluted_earnings_per_share": {"value": -0.2, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "income_loss_from_continuing_operations_after_tax": {"value": -22250000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}}, "cash_flow_statement": {"net_cash_flow_from_financing_activities": {"value": 2905000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_financing_activities_continuing": {"value": 2905000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_continuing": {"value": -151667000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_operating_activities": {"value": -28513000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_operating_activities_continuing": {"value": -28513000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_investing_activities": {"value": -126059000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_investing_activities_continuing": {"value": -126059000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow": {"value": -151667000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}}, "comprehensive_income": {"comprehensive_income_loss": {"value": -22923000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss_attributable_to_parent": {"value": -22923000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "other_comprehensive_income_loss": {"value": -22923000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}}}}, {"start_date": "2024-01-01", "end_date": "2024-03-31", "filing_date": "2024-04-25", "acceptance_datetime": "2024-04-25T00:42:21Z", "timeframe": "quarterly", "fiscal_period": "Q1", "fiscal_year": "2024", "cik": "0001607678", "sic": "2834", "tickers": ["VKTX"], "company_name": "Viking Therapeutics, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-24-047833", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-24-047833/files/vktx-20240331_htm.xml", "financials": {"balance_sheet": {"accounts_payable": {"value": 5225000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "noncurrent_assets": {"value": 1183000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "equity": {"value": 933891000.0, "unit": "USD", "label": "Equity", "order": 1400}, "equity_attributable_to_parent": {"value": 933892000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "assets": {"value": 967518000.0, "unit": "USD", "label": "Assets", "order": 100}, "noncurrent_liabilities": {"value": 852000, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "current_assets": {"value": 966335000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "other_current_liabilities": {"value": 27549000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "liabilities": {"value": 33626000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "liabilities_and_equity": {"value": 967518000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "current_liabilities": {"value": 32774000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}}, "cash_flow_statement": {"net_cash_flow_from_financing_activities": {"value": 606037000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_operating_activities": {"value": -6134000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_operating_activities_continuing": {"value": -6134000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow": {"value": 140111000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_investing_activities": {"value": -459792000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_financing_activities_continuing": {"value": 606037000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_continuing": {"value": 140111000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_investing_activities_continuing": {"value": -459792000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}}, "income_statement": {"revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "income_loss_from_continuing_operations_before_tax": {"value": -27356000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "net_income_loss_attributable_to_parent": {"value": -27356000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "operating_income_loss": {"value": -34073000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "research_and_development": {"value": 24103000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "diluted_earnings_per_share": {"value": -0.26, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "other_operating_expenses": {"value": 9970000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "basic_earnings_per_share": {"value": -0.26, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "income_loss_from_continuing_operations_after_tax": {"value": -27356000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "net_income_loss": {"value": -27356000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "operating_expenses": {"value": 34073000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "net_income_loss_available_to_common_stockholders_basic": {"value": -27356000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "basic_average_shares": {"value": 103457000.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "diluted_average_shares": {"value": 103457000.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}}, "comprehensive_income": {"comprehensive_income_loss": {"value": -28566000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "other_comprehensive_income_loss": {"value": -1210000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_parent": {"value": -28566000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}}}}, {"start_date": "2023-10-01", "end_date": "2023-12-31", "timeframe": "quarterly", "fiscal_period": "Q4", "fiscal_year": "2023", "cik": "0001607678", "sic": "2834", "tickers": ["VKTX"], "company_name": "Viking Therapeutics, Inc.", "financials": {"comprehensive_income": {"comprehensive_income_loss_attributable_to_parent": {"value": -24089000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss": {"value": -24089000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "other_comprehensive_income_loss": {"value": 516000, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}}, "balance_sheet": {"equity": {"value": 348419000.0, "unit": "USD", "label": "Equity", "order": 1400}, "other_current_liabilities": {"value": 11623000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "current_liabilities": {"value": 19135000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "equity_attributable_to_parent": {"value": 348419000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "accounts_payable": {"value": 7512000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "noncurrent_liabilities": {"value": 936000, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "current_assets": {"value": 367225000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "noncurrent_assets": {"value": 1265000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "liabilities_and_equity": {"value": 368490000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "assets": {"value": 368490000.0, "unit": "USD", "label": "Assets", "order": 100}, "liabilities": {"value": 20071000.0, "unit": "USD", "label": "Liabilities", "order": 600}}, "income_statement": {"revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "basic_average_shares": {"value": 1866000.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "research_and_development": {"value": 20502000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "net_income_loss": {"value": -24605000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "operating_expenses": {"value": 29285000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "diluted_average_shares": {"value": 1866000.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "operating_income_loss": {"value": -29285000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "basic_earnings_per_share": {"value": -0.25, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "net_income_loss_attributable_to_parent": {"value": -24605000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "net_income_loss_available_to_common_stockholders_basic": {"value": -24605000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "income_loss_from_continuing_operations_before_tax": {"value": -24604000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "other_operating_expenses": {"value": 8783000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "income_loss_from_continuing_operations_after_tax": {"value": -24605000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "diluted_earnings_per_share": {"value": -0.25, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}}, "cash_flow_statement": {"net_cash_flow_from_operating_activities_continuing": {"value": -17640000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_operating_activities": {"value": -17640000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_financing_activities_continuing": {"value": 188000, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_investing_activities": {"value": 35733000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_continuing": {"value": 18281000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow": {"value": 18281000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_financing_activities": {"value": 188000, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_investing_activities_continuing": {"value": 35733000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}}}}, {"start_date": "2023-07-01", "end_date": "2023-09-30", "filing_date": "2023-10-25", "acceptance_datetime": "2023-10-25T21:05:27Z", "timeframe": "quarterly", "fiscal_period": "Q3", "fiscal_year": "2023", "cik": "0001607678", "sic": "2834", "tickers": ["VKTX"], "company_name": "Viking Therapeutics, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-23-055259", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-23-055259/files/vktx-20230930_htm.xml", "financials": {"balance_sheet": {"other_current_liabilities": {"value": 7694000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "assets": {"value": 382663000.0, "unit": "USD", "label": "Assets", "order": 100}, "current_assets": {"value": 381300000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "noncurrent_assets": {"value": 1363000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "equity_attributable_to_parent": {"value": 368240000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "noncurrent_liabilities": {"value": 1018000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "liabilities": {"value": 14423000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "accounts_payable": {"value": 5711000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "liabilities_and_equity": {"value": 382663000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "equity": {"value": 368240000.0, "unit": "USD", "label": "Equity", "order": 1400}, "current_liabilities": {"value": 13405000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}}, "cash_flow_statement": {"net_cash_flow_from_investing_activities_continuing": {"value": -12534000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_operating_activities_continuing": {"value": -19658000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_financing_activities": {"value": -74000, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_operating_activities": {"value": -19658000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_financing_activities_continuing": {"value": -74000, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_continuing": {"value": -32266000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_investing_activities": {"value": -12534000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow": {"value": -32266000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}}, "comprehensive_income": {"other_comprehensive_income_loss": {"value": -22399000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss": {"value": -22399000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss_attributable_to_parent": {"value": -22399000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}}, "income_statement": {"operating_income_loss": {"value": -27265000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "income_loss_from_continuing_operations_before_tax": {"value": -22534000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "income_loss_from_continuing_operations_after_tax": {"value": -22534000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "diluted_average_shares": {"value": 99846000.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "net_income_loss": {"value": -22534000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "basic_earnings_per_share": {"value": -0.23, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "research_and_development": {"value": 18379000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "net_income_loss_available_to_common_stockholders_basic": {"value": -22534000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "operating_expenses": {"value": 27265000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "basic_average_shares": {"value": 99846000.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "net_income_loss_attributable_to_parent": {"value": -22534000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "diluted_earnings_per_share": {"value": -0.23, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "other_operating_expenses": {"value": 8886000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}}}}, {"start_date": "2023-04-01", "end_date": "2023-06-30", "filing_date": "2023-07-26", "acceptance_datetime": "2023-07-26T20:46:18Z", "timeframe": "quarterly", "fiscal_period": "Q2", "fiscal_year": "2023", "cik": "0001607678", "sic": "2834", "tickers": ["VKTX"], "company_name": "Viking Therapeutics, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-23-034773", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-23-034773/files/vktx-20230630_htm.xml", "financials": {"income_statement": {"net_income_loss": {"value": -19225000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "diluted_earnings_per_share": {"value": -0.19, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "operating_expenses": {"value": 23740000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "net_income_loss_available_to_common_stockholders_basic": {"value": -19225000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "other_operating_expenses": {"value": 9823000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "basic_earnings_per_share": {"value": -0.19, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "basic_average_shares": {"value": 99010000.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "net_income_loss_attributable_to_parent": {"value": -19225000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "research_and_development": {"value": 13917000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "operating_income_loss": {"value": -23740000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "income_loss_from_continuing_operations_before_tax": {"value": -19225000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "diluted_average_shares": {"value": 99010000.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "income_loss_from_continuing_operations_after_tax": {"value": -19225000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}}, "comprehensive_income": {"comprehensive_income_loss": {"value": -19647000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "other_comprehensive_income_loss": {"value": -19647000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss_attributable_to_parent": {"value": -19647000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}}, "balance_sheet": {"noncurrent_assets": {"value": 1322000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "other_current_liabilities": {"value": 7867000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "current_liabilities": {"value": 13478000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "liabilities": {"value": 14578000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "current_assets": {"value": 399371000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "noncurrent_liabilities": {"value": 1100000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "assets": {"value": 400693000.0, "unit": "USD", "label": "Assets", "order": 100}, "liabilities_and_equity": {"value": 400693000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "accounts_payable": {"value": 5611000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "equity": {"value": 386115000.0, "unit": "USD", "label": "Equity", "order": 1400}, "equity_attributable_to_parent": {"value": 386115000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}}, "cash_flow_statement": {"net_cash_flow_from_investing_activities_continuing": {"value": -204483000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_operating_activities": {"value": -11435000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_investing_activities": {"value": -204483000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow": {"value": 51160000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_continuing": {"value": 51160000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_financing_activities": {"value": 267078000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_operating_activities_continuing": {"value": -11435000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_financing_activities_continuing": {"value": 267078000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}}}}, {"start_date": "2023-01-01", "end_date": "2023-03-31", "filing_date": "2023-04-26", "acceptance_datetime": "2023-04-26T21:01:07Z", "timeframe": "quarterly", "fiscal_period": "Q1", "fiscal_year": "2023", "cik": "0001607678", "sic": "2834", "tickers": ["VKTX"], "company_name": "Viking Therapeutics, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-23-014883", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-23-014883/files/vktx-20230331_htm.xml", "financials": {"cash_flow_statement": {"net_cash_flow_from_financing_activities_continuing": {"value": 4184000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_investing_activities": {"value": 2198000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_investing_activities_continuing": {"value": 2198000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_operating_activities": {"value": -24643000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_continuing": {"value": -18261000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_operating_activities_continuing": {"value": -24643000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow": {"value": -18261000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_financing_activities": {"value": 4184000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}}, "income_statement": {"diluted_average_shares": {"value": 78352000.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "income_loss_from_continuing_operations_after_tax": {"value": -19531000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "basic_average_shares": {"value": 78352000.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "operating_expenses": {"value": 20537000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "diluted_earnings_per_share": {"value": -0.25, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "other_operating_expenses": {"value": 9529000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "income_loss_from_continuing_operations_before_tax": {"value": -19531000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "net_income_loss_attributable_to_parent": {"value": -19531000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "operating_income_loss": {"value": -20537000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "net_income_loss_available_to_common_stockholders_basic": {"value": -19531000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "net_income_loss": {"value": -19531000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "research_and_development": {"value": 11008000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "basic_earnings_per_share": {"value": -0.25, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "other_comprehensive_income_loss": {"value": 484000, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_parent": {"value": -19047000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss": {"value": -19047000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}}, "balance_sheet": {"noncurrent_liabilities": {"value": 1181000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "accounts_payable": {"value": 3799000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "equity_attributable_to_parent": {"value": 134065000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "current_liabilities": {"value": 15649000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "liabilities_and_equity": {"value": 150895000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "liabilities": {"value": 16830000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "other_current_liabilities": {"value": 11850000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "noncurrent_assets": {"value": 1427000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "assets": {"value": 150895000.0, "unit": "USD", "label": "Assets", "order": 100}, "equity": {"value": 134065000.0, "unit": "USD", "label": "Equity", "order": 1400}, "current_assets": {"value": 149468000.0, "unit": "USD", "label": "Current Assets", "order": 200}}}}, {"start_date": "2022-10-01", "end_date": "2022-12-31", "timeframe": "quarterly", "fiscal_period": "Q4", "fiscal_year": "2022", "cik": "0001607678", "sic": "2834", "tickers": ["VKTX"], "company_name": "Viking Therapeutics, Inc.", "financials": {"income_statement": {"other_operating_expenses": {"value": 4105000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "diluted_earnings_per_share": {"value": -0.26, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "income_loss_from_continuing_operations_before_tax": {"value": -19558000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "net_income_loss_available_to_common_stockholders_basic": {"value": -19559000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "net_income_loss": {"value": -19559000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "net_income_loss_attributable_to_parent": {"value": -19559000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "diluted_average_shares": {"value": -83000, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "research_and_development": {"value": 16178000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "income_loss_from_continuing_operations_after_tax": {"value": -19559000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "basic_earnings_per_share": {"value": -0.26, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "operating_income_loss": {"value": -20283000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "operating_expenses": {"value": 20283000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "basic_average_shares": {"value": -83000, "unit": "shares", "label": "Basic Average Shares", "order": 4400}}, "cash_flow_statement": {"net_cash_flow_from_financing_activities_continuing": {"value": 10749000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_operating_activities_continuing": {"value": -10926000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow": {"value": 7083000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_operating_activities": {"value": -10926000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_investing_activities_continuing": {"value": 7260000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_investing_activities": {"value": 7260000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_financing_activities": {"value": 10749000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_continuing": {"value": 7083000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}}, "comprehensive_income": {"comprehensive_income_loss": {"value": -18900000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss_attributable_to_parent": {"value": -18900000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "other_comprehensive_income_loss": {"value": 659000, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}}, "balance_sheet": {"liabilities_and_equity": {"value": 168529000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "noncurrent_assets": {"value": 1489000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "current_liabilities": {"value": 21947000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "equity_attributable_to_parent": {"value": 145322000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "liabilities": {"value": 23207000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "equity": {"value": 145322000.0, "unit": "USD", "label": "Equity", "order": 1400}, "accounts_payable": {"value": 8529000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "noncurrent_liabilities": {"value": 1260000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "other_current_liabilities": {"value": 13418000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "current_assets": {"value": 167040000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "assets": {"value": 168529000.0, "unit": "USD", "label": "Assets", "order": 100}}}}, {"start_date": "2022-07-01", "end_date": "2022-09-30", "filing_date": "2022-10-26", "timeframe": "quarterly", "fiscal_period": "Q3", "fiscal_year": "2022", "cik": "0001607678", "sic": "2834", "tickers": ["VKTX"], "company_name": "Viking Therapeutics, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001564590-22-035295", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001564590-22-035295/files/vktx-10q_20220930_htm.xml", "financials": {"comprehensive_income": {"comprehensive_income_loss": {"value": -15885000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_parent": {"value": -15885000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "other_comprehensive_income_loss": {"value": -15885000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}}, "cash_flow_statement": {"net_cash_flow_from_investing_activities_continuing": {"value": 26894000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_operating_activities_continuing": {"value": -13499000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_continuing": {"value": 13405000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_financing_activities_continuing": {"value": 10000, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_investing_activities": {"value": 26894000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow": {"value": 13405000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_operating_activities": {"value": -13499000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_financing_activities": {"value": 10000, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}}, "balance_sheet": {"noncurrent_assets": {"value": 1537000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "equity_attributable_to_parent": {"value": 151285000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "equity": {"value": 151285000.0, "unit": "USD", "label": "Equity", "order": 1400}, "liabilities_and_equity": {"value": 166683000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "current_assets": {"value": 165146000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "assets": {"value": 166683000.0, "unit": "USD", "label": "Assets", "order": 100}, "other_current_liabilities": {"value": 10919000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "accounts_payable": {"value": 3142000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "liabilities": {"value": 15398000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "noncurrent_liabilities": {"value": 1337000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "current_liabilities": {"value": 14061000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}}, "income_statement": {"diluted_average_shares": {"value": 76505000.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "operating_expenses": {"value": 16196000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "operating_income_loss": {"value": -16196000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "net_income_loss_attributable_to_parent": {"value": -15773000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "research_and_development": {"value": 11959000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "basic_earnings_per_share": {"value": -0.21, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "income_loss_from_continuing_operations_after_tax": {"value": -15773000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "basic_average_shares": {"value": 76505000.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "diluted_earnings_per_share": {"value": -0.21, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "net_income_loss": {"value": -15773000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "income_loss_from_continuing_operations_before_tax": {"value": -15773000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "other_operating_expenses": {"value": 4237000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "net_income_loss_available_to_common_stockholders_basic": {"value": -15773000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}}}}, {"start_date": "2022-04-01", "end_date": "2022-06-30", "filing_date": "2022-07-27", "timeframe": "quarterly", "fiscal_period": "Q2", "fiscal_year": "2022", "cik": "0001607678", "sic": "2834", "tickers": ["VKTX"], "company_name": "Viking Therapeutics, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001564590-22-026717", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001564590-22-026717/files/vktx-10q_20220630_htm.xml", "financials": {"comprehensive_income": {"comprehensive_income_loss_attributable_to_parent": {"value": -17670000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "other_comprehensive_income_loss": {"value": -17670000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss": {"value": -17670000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}}, "income_statement": {"income_loss_from_continuing_operations_after_tax": {"value": -17432000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "diluted_earnings_per_share": {"value": -0.23, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "basic_earnings_per_share": {"value": -0.23, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "operating_income_loss": {"value": -17631000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "net_income_loss": {"value": -17432000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "income_loss_from_continuing_operations_before_tax": {"value": -17432000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "diluted_average_shares": {"value": 76842000.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "net_income_loss_attributable_to_parent": {"value": -17432000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "net_income_loss_available_to_common_stockholders_basic": {"value": -17432000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "research_and_development": {"value": 13542000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "other_operating_expenses": {"value": 4089000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "basic_average_shares": {"value": 76842000.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "operating_expenses": {"value": 17631000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}}, "balance_sheet": {"current_liabilities": {"value": 14864000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "noncurrent_liabilities": {"value": 1414000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "equity_attributable_to_parent": {"value": 165230000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "noncurrent_assets": {"value": 1645000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "current_assets": {"value": 179863000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "equity": {"value": 165230000.0, "unit": "USD", "label": "Equity", "order": 1400}, "liabilities_and_equity": {"value": 181508000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "accounts_payable": {"value": 6104000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "assets": {"value": 181508000.0, "unit": "USD", "label": "Assets", "order": 100}, "other_current_liabilities": {"value": 8760000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "liabilities": {"value": 16278000.0, "unit": "USD", "label": "Liabilities", "order": 600}}, "cash_flow_statement": {"net_cash_flow_from_operating_activities_continuing": {"value": -13442000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_continuing": {"value": 3948000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_operating_activities": {"value": -13442000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow": {"value": 3948000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_financing_activities": {"value": -1590000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_financing_activities_continuing": {"value": -1590000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_investing_activities": {"value": 18980000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_investing_activities_continuing": {"value": 18980000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}}}}, {"start_date": "2022-01-01", "end_date": "2022-03-31", "filing_date": "2022-04-27", "timeframe": "quarterly", "fiscal_period": "Q1", "fiscal_year": "2022", "cik": "0001607678", "sic": "2834", "tickers": ["VKTX"], "company_name": "Viking Therapeutics, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001564590-22-016129", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001564590-22-016129/files/vktx-10q_20220331_htm.xml", "financials": {"income_statement": {"basic_earnings_per_share": {"value": -0.19999999999999998, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "other_operating_expenses": {"value": 3690000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "diluted_earnings_per_share": {"value": -0.19999999999999998, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "basic_average_shares": {"value": 284000, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "net_income_loss_attributable_to_parent": {"value": -16103000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "operating_expenses": {"value": 16245000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "net_income_loss_available_to_common_stockholders_basic": {"value": -16103000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "income_loss_from_continuing_operations_after_tax": {"value": -16103000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "net_income_loss": {"value": -16103000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "income_loss_from_continuing_operations_before_tax": {"value": -16103000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "research_and_development": {"value": 12555000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "diluted_average_shares": {"value": 284000, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "operating_income_loss": {"value": -16245000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}}, "cash_flow_statement": {"net_cash_flow_from_financing_activities_continuing": {"value": -5006000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_financing_activities": {"value": -5006000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_investing_activities_continuing": {"value": 1619000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_operating_activities": {"value": -10530000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_investing_activities": {"value": 1619000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_operating_activities_continuing": {"value": -10530000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow": {"value": -13917000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_continuing": {"value": -13917000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}}, "comprehensive_income": {"comprehensive_income_loss": {"value": -16965000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "other_comprehensive_income_loss": {"value": -862000, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss_attributable_to_parent": {"value": -16965000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}}, "balance_sheet": {"assets": {"value": 195028000.0, "unit": "USD", "label": "Assets", "order": 100}, "noncurrent_liabilities": {"value": 1490000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "noncurrent_assets": {"value": 1729000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "equity_attributable_to_parent": {"value": 182270000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "equity": {"value": 182270000.0, "unit": "USD", "label": "Equity", "order": 1400}, "other_current_liabilities": {"value": 8149000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "current_assets": {"value": 193299000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "current_liabilities": {"value": 11268000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "liabilities_and_equity": {"value": 195028000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "accounts_payable": {"value": 3119000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "liabilities": {"value": 12758000.0, "unit": "USD", "label": "Liabilities", "order": 600}}}}, {"start_date": "2021-10-01", "end_date": "2021-12-31", "timeframe": "quarterly", "fiscal_period": "Q4", "fiscal_year": "2021", "cik": "0001607678", "sic": "2834", "tickers": ["VKTX", "VKTXW"], "company_name": "Viking Therapeutics, Inc.", "financials": {"balance_sheet": {"liabilities": {"value": 8778000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "current_assets": {"value": 210528000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "accounts_payable": {"value": 1444000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "noncurrent_assets": {"value": 134000, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "equity": {"value": 201884000.0, "unit": "USD", "label": "Equity", "order": 1400}, "equity_attributable_to_parent": {"value": 201884000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "assets": {"value": 210662000.0, "unit": "USD", "label": "Assets", "order": 100}, "liabilities_and_equity": {"value": 210662000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "current_liabilities": {"value": 8778000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "other_current_liabilities": {"value": 7334000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}}, "cash_flow_statement": {"net_cash_flow_from_financing_activities": {"value": 47000, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_financing_activities_continuing": {"value": 47000, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_continuing": {"value": 15107000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow": {"value": 15107000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_operating_activities_continuing": {"value": -12350000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_investing_activities_continuing": {"value": 27410000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_investing_activities": {"value": 27410000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_operating_activities": {"value": -12350000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}}, "income_statement": {"operating_expenses": {"value": 12510000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "net_income_loss": {"value": -12356000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "research_and_development": {"value": 9847000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "income_loss_from_continuing_operations_after_tax": {"value": -12356000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "net_income_loss_attributable_to_parent": {"value": -12356000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "net_income_loss_available_to_common_stockholders_basic": {"value": -12356000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "other_operating_expenses": {"value": 2663000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "operating_income_loss": {"value": -12510000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "income_loss_from_continuing_operations_before_tax": {"value": -12354000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}}, "comprehensive_income": {"other_comprehensive_income_loss": {"value": -379000, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_parent": {"value": -12735000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss": {"value": -12735000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}}}}, {"start_date": "2021-07-01", "end_date": "2021-09-30", "filing_date": "2021-11-03", "timeframe": "quarterly", "fiscal_period": "Q3", "fiscal_year": "2021", "cik": "0001607678", "sic": "2834", "tickers": ["VKTX"], "company_name": "Viking Therapeutics, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001564590-21-054030", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001564590-21-054030/files/vktx-10q_20210930_htm.xml", "financials": {"income_statement": {"other_operating_expenses": {"value": 2608000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "income_loss_from_continuing_operations_before_tax": {"value": -13243000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "research_and_development": {"value": 10795000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "operating_expenses": {"value": 13403000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "income_loss_from_continuing_operations_after_tax": {"value": -13243000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "net_income_loss_available_to_common_stockholders_basic": {"value": -13243000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "net_income_loss": {"value": -13243000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "net_income_loss_attributable_to_parent": {"value": -13243000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "operating_income_loss": {"value": -13403000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}}, "comprehensive_income": {"comprehensive_income_loss": {"value": -13224000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "other_comprehensive_income_loss": {"value": -13224000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_parent": {"value": -13224000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}}, "balance_sheet": {"noncurrent_assets": {"value": 189000, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "assets": {"value": 224474000.0, "unit": "USD", "label": "Assets", "order": 100}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "equity_attributable_to_parent": {"value": 213121000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "equity": {"value": 213121000.0, "unit": "USD", "label": "Equity", "order": 1400}, "other_current_liabilities": {"value": 8501000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "current_assets": {"value": 224285000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "accounts_payable": {"value": 2852000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "current_liabilities": {"value": 11353000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "liabilities_and_equity": {"value": 224474000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "liabilities": {"value": 11353000.0, "unit": "USD", "label": "Liabilities", "order": 600}}, "cash_flow_statement": {"net_cash_flow_from_investing_activities": {"value": 13617000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_continuing": {"value": 2435000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_investing_activities_continuing": {"value": 13617000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_financing_activities_continuing": {"value": -256000, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_operating_activities": {"value": -10926000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_financing_activities": {"value": -256000, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow": {"value": 2435000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_operating_activities_continuing": {"value": -10926000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}}}}, {"start_date": "2021-04-01", "end_date": "2021-06-30", "filing_date": "2021-07-28", "timeframe": "quarterly", "fiscal_period": "Q2", "fiscal_year": "2021", "cik": "0001607678", "sic": "2834", "tickers": ["VKTX"], "company_name": "Viking Therapeutics, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001564590-21-038663", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001564590-21-038663/files/vktx-10q_20210630_htm.xml", "financials": {"income_statement": {"net_income_loss_available_to_common_stockholders_basic": {"value": -15381000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "other_operating_expenses": {"value": 2737000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "operating_income_loss": {"value": -15541000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "income_loss_from_continuing_operations_after_tax": {"value": -15381000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "net_income_loss": {"value": -15381000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "net_income_loss_attributable_to_parent": {"value": -15381000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "research_and_development": {"value": 12804000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "operating_expenses": {"value": 15541000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "income_loss_from_continuing_operations_before_tax": {"value": -15381000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_parent": {"value": -15466000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss": {"value": -15466000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "other_comprehensive_income_loss": {"value": -15466000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}}, "cash_flow_statement": {"net_cash_flow_from_operating_activities_continuing": {"value": -13434000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_financing_activities_continuing": {"value": 1898000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_investing_activities": {"value": 3560000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_continuing": {"value": -7976000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_investing_activities_continuing": {"value": 3560000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_financing_activities": {"value": 1898000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow": {"value": -7976000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_operating_activities": {"value": -13434000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}}, "balance_sheet": {"equity": {"value": 224974000.0, "unit": "USD", "label": "Equity", "order": 1400}, "liabilities": {"value": 12871000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "accounts_payable": {"value": 4210000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "liabilities_and_equity": {"value": 237845000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "noncurrent_assets": {"value": 183000, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "other_current_liabilities": {"value": 8661000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "current_assets": {"value": 237662000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "current_liabilities": {"value": 12871000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "assets": {"value": 237845000.0, "unit": "USD", "label": "Assets", "order": 100}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "equity_attributable_to_parent": {"value": 224974000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}}}}, {"start_date": "2021-01-01", "end_date": "2021-03-31", "filing_date": "2021-04-28", "timeframe": "quarterly", "fiscal_period": "Q1", "fiscal_year": "2021", "cik": "0001607678", "sic": "2834", "tickers": ["VKTX", "VKTXW"], "company_name": "Viking Therapeutics, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001564590-21-021430", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001564590-21-021430/files/vktx-10q_20210331_htm.xml", "financials": {"comprehensive_income": {"comprehensive_income_loss_attributable_to_parent": {"value": -14060000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss": {"value": -14060000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "other_comprehensive_income_loss": {"value": -50000, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}}, "balance_sheet": {"current_assets": {"value": 249863000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "current_liabilities": {"value": 12916000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "noncurrent_assets": {"value": 276000, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "equity": {"value": 237223000.0, "unit": "USD", "label": "Equity", "order": 1400}, "accounts_payable": {"value": 4848000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "assets": {"value": 250139000.0, "unit": "USD", "label": "Assets", "order": 100}, "equity_attributable_to_parent": {"value": 237223000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "liabilities": {"value": 12916000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "other_current_liabilities": {"value": 8068000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "liabilities_and_equity": {"value": 250139000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}}, "income_statement": {"income_loss_from_continuing_operations_before_tax": {"value": -14010000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "income_loss_from_continuing_operations_after_tax": {"value": -14010000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "operating_income_loss": {"value": -14228000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "net_income_loss_attributable_to_parent": {"value": -14010000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "research_and_development": {"value": 11535000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "operating_expenses": {"value": 14228000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "other_operating_expenses": {"value": 2693000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "net_income_loss_available_to_common_stockholders_basic": {"value": -14010000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "net_income_loss": {"value": -14010000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}}, "cash_flow_statement": {"net_cash_flow_from_financing_activities": {"value": 5191000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_operating_activities": {"value": -10876000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_financing_activities_continuing": {"value": 5191000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_operating_activities_continuing": {"value": -10876000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow": {"value": -12312000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_investing_activities_continuing": {"value": -6627000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_continuing": {"value": -12312000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_investing_activities": {"value": -6627000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}}}}, {"start_date": "2020-10-01", "end_date": "2020-12-31", "timeframe": "quarterly", "fiscal_period": "Q4", "fiscal_year": "2020", "cik": "0001607678", "sic": "2834", "tickers": ["VKTX", "VKTXW"], "company_name": "Viking Therapeutics, Inc.", "financials": {"balance_sheet": {"noncurrent_liabilities": {"value": 29000, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "liabilities": {"value": 12158000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "equity_attributable_to_parent": {"value": 244344000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "noncurrent_assets": {"value": 398000, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "liabilities_and_equity": {"value": 256502000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "equity": {"value": 244344000.0, "unit": "USD", "label": "Equity", "order": 1400}, "assets": {"value": 256502000.0, "unit": "USD", "label": "Assets", "order": 100}, "accounts_payable": {"value": 3988000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "other_current_liabilities": {"value": 8141000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "current_assets": {"value": 256104000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "current_liabilities": {"value": 12129000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}}, "cash_flow_statement": {"net_cash_flow_from_financing_activities": {"value": 464000, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_investing_activities_continuing": {"value": 30269000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow": {"value": 25247000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_investing_activities": {"value": 30269000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_financing_activities_continuing": {"value": 464000, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_operating_activities": {"value": -5486000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_operating_activities_continuing": {"value": -5486000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_continuing": {"value": 25247000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}}, "comprehensive_income": {"other_comprehensive_income_loss": {"value": -8000, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss": {"value": -10956000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss_attributable_to_parent": {"value": -10956000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}}, "income_statement": {"research_and_development": {"value": 9049000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "operating_expenses": {"value": 11266000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "net_income_loss_attributable_to_parent": {"value": -10948000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "other_operating_expenses": {"value": 2217000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "net_income_loss_available_to_common_stockholders_basic": {"value": -10948000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "operating_income_loss": {"value": -11266000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "net_income_loss": {"value": -10948000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "income_loss_from_continuing_operations_before_tax": {"value": -10948000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "income_loss_from_continuing_operations_after_tax": {"value": -10948000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}}}}]